Evidence on safety

Comprehensive reviews and evaluations by public-health bodies and scientific authorities consistently find no convincing evidence that CWF at recommended fluoride concentrations causes significant adverse health outcomes in the general population.

For example, a recent major evidence review from New Zealand concluded that water fluoridation remains a safe and effective public health intervention, and that “no high-quality evidence” has emerged since prior reviews to establish a causal link between exposure at CWF levels and serious health harms.

Similarly, population-level data and epidemiological studies have not demonstrated consistent associations between optimal water-fluoride concentrations and increased risks of cancer, neurological disease, bone disease, or other chronic conditions.

The only widely accepted adverse effect of fluoride at systemic exposure levels typical for CWF is enamel fluorosis — and even then, this is primarily at low-to-mild levels (cosmetic, not pathological) where fluoride intake during tooth development is modestly elevated.

Health benefits beyond dental decay prevention

Because dental decay and poor oral health are themselves major contributors to pain, infection, tooth loss, and reduced quality of life — and may indirectly influence nutrition, social participation, general wellbeing and health-care costs — the caries-preventive effect of CWF represents a broader public-health benefit. By preventing tooth decay across the population (children and adults alike), CWF reduces the need for dental treatment, lowers the burden of dental disease, and may contribute to improved general health and wellbeing.

Furthermore, because CWF delivers fluoride passively and universally (regardless of individual behaviour, income or access to dental care), it helps reach populations who may otherwise be at risk of poor oral health due to socioeconomic or access barriers — thereby contributing to health equity.

Addressing concerns and uncertainties

Some recent studies and reviews — particularly those examining neurodevelopmental outcomes or other health endpoints from high-fluoride areas — have raised concerns about possible adverse effects (for example on cognition or general development).

However, authoritative recent reviews that have explicitly considered these concerns in the context of CWF-level fluoride exposure conclude that the evidence remains insufficient to establish a causal link.

Specifically: research from regions with naturally high fluoride levels — often substantially above those used in regulated CWF programmes — may not be generalisable to areas where fluoride is strictly controlled and dosing is monitored.

In short, while ongoing monitoring and good-quality research remain important, the current evidence base does not support claims of systemic health harms from fluoride exposure at levels typically used in CWF schemes.

Systemic Fluoride Exposure and Regulation

• Fluoride exposure from CWF remains well below safety thresholds set by the World Health Organization (WHO), U.S. Environmental Protection Agency (EPA), and European Food Safety Authority (EFSA).
• The tolerable upper intake level (UL) for fluoride is 10 mg/day for adults (EPA, 2010), and average intake from fluoridated water is significantly lower (typically 1-2 mg/day).

Urinary fluoride levels in fluoridated communities are within the expected range for safe fluoride intake and do not exceed toxicological thresholds (Buzalaf et al., 2011).